These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38466523)

  • 21. Dual time point 2-[18F]fluoro-2'-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis.
    Sahlmann CO; Siefker U; Lehmann K; Meller J
    Nucl Med Commun; 2004 Aug; 25(8):819-23. PubMed ID: 15266177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume.
    Rockall AG; Avril N; Lam R; Iannone R; Mozley PD; Parkinson C; Bergstrom D; Sala E; Sarker SJ; McNeish IA; Brenton JD
    Clin Cancer Res; 2014 May; 20(10):2751-60. PubMed ID: 24573555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis.
    de Langen AJ; Vincent A; Velasquez LM; van Tinteren H; Boellaard R; Shankar LK; Boers M; Smit EF; Stroobants S; Weber WA; Hoekstra OS
    J Nucl Med; 2012 May; 53(5):701-8. PubMed ID: 22496583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeatability of quantitative
    Kramer GM; Liu Y; de Langen AJ; Jansma EP; Trigonis I; Asselin MC; Jackson A; Kenny L; Aboagye EO; Hoekstra OS; Boellaard R;
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):951-961. PubMed ID: 29362858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.
    Heijmen L; de Geus-Oei LF; de Wilt JH; Visvikis D; Hatt M; Visser EP; Bussink J; Punt CJ; Oyen WJ; van Laarhoven HW
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1858-67. PubMed ID: 22945372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications.
    García Vicente AM; Soriano Castrejón AM; Talavera Rubio MP; León Martín AA; Palomar Muñoz AM; Pilkington Woll JP; Poblete García VM
    Ann Nucl Med; 2010 Apr; 24(3):207-14. PubMed ID: 20177834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak.
    Laffon E; Lamare F; de Clermont H; Burger IA; Marthan R
    Eur Radiol; 2014 Aug; 24(8):1964-70. PubMed ID: 24895030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
    Caprio MG; Cangiano A; Imbriaco M; Soscia F; Di Martino G; Farina A; Avitabile G; Pace L; Forestieri P; Salvatore M
    Radiol Med; 2010 Mar; 115(2):215-24. PubMed ID: 20017002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.
    Kahraman D; Scheffler M; Zander T; Nogova L; Lammertsma AA; Boellaard R; Neumaier B; Ullrich RT; Holstein A; Dietlein M; Wolf J; Kobe C
    J Nucl Med; 2011 Dec; 52(12):1871-7. PubMed ID: 22065872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
    Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
    Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body
    Dias AH; Pedersen MF; Danielsen H; Munk OL; Gormsen LC
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):837-850. PubMed ID: 32894338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
    Huang YE; Chen CF; Huang YJ; Konda SD; Appelbaum DE; Pu Y
    Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study.
    Jena A; Taneja S; Goel R; Renjen P; Negi P
    Eur J Radiol; 2014 Jul; 83(7):1269-1274. PubMed ID: 24813529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First results on kinetic modelling and parametric imaging of dynamic
    Sari H; Mingels C; Alberts I; Hu J; Buesser D; Shah V; Schepers R; Caluori P; Panin V; Conti M; Afshar-Oromieh A; Shi K; Eriksson L; Rominger A; Cumming P
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1997-2009. PubMed ID: 34981164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Test-retest repeatability and interobserver variation of healthy tissue metabolism using 18F-FDG PET/CT of the thorax among lung cancer patients.
    Malaih AA; Dunn JT; Nygård L; Kovacs DG; Andersen FL; Barrington SF; Fischer BM
    Nucl Med Commun; 2022 May; 43(5):549-559. PubMed ID: 35081091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incremental Value of 18 F-FDG-Labeled Leukocytes PET/CT Over 18 F-FDG PET/CT Scan in the Detection of Occult Infection.
    Manda D; Thakral P; Sen I; Das SS; Cb V; Malik D
    Clin Nucl Med; 2022 Sep; 47(9):e574-e581. PubMed ID: 35776834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Test-Retest Stability of Cerebral 2-Deoxy-2-[
    Sijbesma JWA; van Waarde A; Vállez García D; Boersma HH; Slart RHJA; Dierckx RAJO; Doorduin J
    Mol Imaging Biol; 2019 Apr; 21(2):240-248. PubMed ID: 29987619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of parametric K
    Wu J; Liu H; Ye Q; Gallezot JD; Naganawa M; Miao T; Lu Y; Chen MK; Esserman DA; Kyriakides TC; Carson RE; Liu C
    Med Phys; 2021 Sep; 48(9):5219-5231. PubMed ID: 34287939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.